The analysis predicted that GLP-1 drugs could prevent thousands of cases of diabetes and cardiovascular disease and add months of high-quality life to patient lifetimes on average
It belongs to a novel class of drugs known as triple agonists, meaning it simultaneously activates three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors
Dulaglutide causes GI adverse reactions but has a lower probability of being unbearable
MNT had the opportunity to speak with Anton Bilchik, MD, PhD, a surgical oncologist, chief of medicine and director of the Gastrointestinal and Hepatobiliary Program at Providence Saint Johns Cancer Institute in Santa Monica, CA, about this study
These programs can reduce brand-name costs to $0 to $500/month, though eligibility restrictions apply and coverage can change with little notice
Neither men nor women should rush the dose escalation